<DOC>
	<DOC>NCT00289614</DOC>
	<brief_summary>The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue (iopamidol) or Visipaque in diabetic patients with moderate to severe chronic renal impairment undergoing clinically indicated contrast enhanced multidetector computed tomography (MDCT). Serum creatinine will be measured before and up to 48-72 hours post dose.</brief_summary>
	<brief_title>Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Referred for contrast enhanced MDCT Documented predose eGFR of greater than or equal to 20 and less than 60 mL/min/1.73m2 Diagnosed as having diabetes mellitus Unstable renal function Unstable diabetes Concurrent administration of nephrotoxic drugs Undergoing dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>contrast induced nephropathy</keyword>
</DOC>